Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP

2024-05-29 10:00:00

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life, the leader in psychobiotics, has begun worldwide expansion after finding success in the United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. Bened life is now spreading love and happiness to Asian markets, Australia and New Zealand.

Bened Life enters global market, expanding footprints with Neuralli MP.
Bened Life enters global market, expanding footprints with Neuralli MP.

What Does Your "Gut" Tell You?

Feeling "butterflies" in the stomach is an example of the gut and brain communicating via the gut-brain axis (GBA) - the bi-directional communication between the gut and the central nervous system (CNS), explaining how the microbiome in the gut affects the brain. Neurological conditions come with chronic discomforts, including GI issues, anxiety, sleep disorders, and depression, appearing to have a persistent imbalance of the gut microbiome. Probiotics are not new in the market, but not all strains are equivalent. Scientific findings demonstrate that PS128™ is a novel psychobiotic (neurobiotic) that appears to balance the "happy hormones" serotonin and dopamine, the "stress hormone" cortisol, and other molecules that affect mind, mood, and movement while regulating gut health.

Major Breakthrough in Probiotics

Neuralli™ MP, powered by the unique strain Lactobacillus plantarum PS128™, is the leading US medical probiotic that supports people with autism spectrum disorder (ASD), autism with ADHD-like traits, Parkinson's Disease (PD), and depression. PS128™ is a natural ingredient self-affirmed as "generally recognized as safe"(GRAS) with 28 patents in 17 countries, backed by 14 clinical studies. PS128™ is also the winner of "Best Probiotic of the Year in 2018 &  2021" by NutraIngredients Asia.

"Neurobiotics such as PS128 show promising abilities to act on the GBA and support neurodevelopmental disorders such as autism," said Dr. Jack Gilbert, a UCSD professor whose research focuses on the microbiome. "We are excited to look into how future studies may address important outcomes identified by the neurodivergent population."

Gut-friendly Psychobiotics: A Natural Alternative

More people have begun to pay attention to mental and neurological health. According to the World Health Organization (WHO), during the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by 25%. It is challenging to look for an add-on therapy that is not a medication, especially when it involves long-term use, which could potentially lead to adverse effects.

Neuralli™ MP offers the best quality in most possible ways. It is safe to consume without side effects, making a meaningful impact on individuals and families globally. K T., mother to an autistic teenager, said "I am noticing significant improvements in her ability to handle stress which would normally result in meltdowns. This probiotic really seems to be making a difference for her and I am so thankful to find this aid for her that is not a medication." 

Neuralli™ MP serves the community with solid scientific evidence, supporting neurodivergent people to live to their full potential.

A Look into the Future

Bened Life is committed to providing high-quality, science-backed psychobiotics that support mental and neurological health. With 1M products sold and hundreds of customer reviews, Neuralli™ MP is ready for its Asian debut. "The venture into Asian markets is a significant milestone for Bened Life. This strategic move aims to introduce the leading gut-brain medical probiotic, Neuralli™ MP, and cater to the special needs of the neurodivergence market in Asia," says Frankie Cheng, CEO of Bened Life.

To opt into this amazing probiotic journey is no longer a fantasy in Hong Kong, Singapore, South Korea, the Philippines, Vietnam, and Indonesia as Bened Life continues to expand into new territories; Neuralli™ MP is now available via Bened Life official website - enjoy door-to-door international delivery with one click!

Link

PR Newswire News

2024-06-14
15:15:00
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
14:00:00
Dun & Bradstreet and HSBC team up to support Hong Kong businesses embark on their ESG journeys
13:00:00
Aspen Digital Receives In-Principle Approval for a Financial Services Permission to operate out of Abu Dhabi Global Market
08:34:00
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
2024-06-13
21:48:00
The Impact Rankings 2024: KIIT Tops Among Most Impactful Universities in India, Ranks 6th Globally
20:57:00
Second edition of Asia New Vision Forum will be held in Singapore from 25 to 27 September 2024
20:30:00
CLPS Incorporation Successfully Acquires Shell Infotech, Accelerating Global Expansion Strategy
19:16:00
Concordia International School Shanghai Named in Top 10 Shortlist for World's Best School Prizes
18:03:00
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy
16:41:00
China Telecom Accredited with "Asia's Best CSR" by Corporate Governance Asia for 5 Consecutive Years
13:42:00
People in Hong Kong Face Big Gap in Achieving Desired Financial, Mental, and Physical Well-being
11:57:00
USPACE Technology Group's First Test Satellite Manufactured for Brazil's Alya Space Successfully Leaves the Production Line
09:53:00
Xinhua Silk Road: Guotai Junan International submits 3rd CoP to UN Global Compact, reporting progress in corporate sustainability
08:02:00
Stagwell (STGW) Expands Asia-Pacific Capabilities with the Additions of Agency, Arena Media, Lodestar Marketing and R&D Online Marketing Services to its Global Affiliate Network
08:00:00
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
2024-06-12
22:25:00
Tata Communications announces five-year host broadcasting services deal with World Athletics
19:51:00
Latest Updates of Viva Biotech's Portfolio Companies
19:28:00
Baozun Announces Results of Annual General Meeting of Shareholders
19:26:00
Baozun Announces Results of Annual General Meeting of Shareholders
18:49:00
Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend
Back to Top